The global multiplex assays market size is expected to reach USD 8,136.7 million by 2032, according to a new study by Polaris Market Research. The report “Multiplex Assays Market Share, Size, Trends, Industry Analysis Report, By Type; By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is driven by the increased prevalence of chronic disorders like cancer, where multiplex tests are commonly used. Rapid advancements in nanotechnology and the numerous advantages of multiplex assays also contribute to market growth. Government funding, research efforts in the pharmaceutical and biotechnology sectors, and the focus on improving experimental efficiency are further propelling the market. Recognizing the multifactorial nature of diseases such as cancer and Alzheimer's has created a demand for cost-effective and time-saving technologies that can assess multiple analytes in a single sample. This factor is driving the adoption of multiplex tests. The rise of companion diagnostics, essential for personalized treatment, is also expected to impact the market significantly.
However, the high costs associated with purchasing and using multiplex assays, stringent government regulations, and the need for affordable healthcare services pose challenges to market expansion. Additionally, the complexity of clinical trial methodologies is hindering market growth. Nevertheless, ongoing research and development efforts hold promise for the future of the global multiplex assay market.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/multiplex-assays-market/request-for-sample
The multiplex assays market has grown significantly due to notable acquisitions and advancements by major players. One such acquisition was the purchase of GRAIL, a healthcare startup focused on early cancer diagnosis, by Illumina. While undergoing regulatory examination by the European Commission, Illumina has maintained GRAIL as a separate entity. Similarly, Thermo Fisher Scientific acquired Mesa Biotech, a point-of-care molecular diagnostic company, in February 2021, further driving market growth. These acquisitions by key players have contributed to expanding the market.
Additionally, in August 2021, Becton, Dickinson, and Company introduced the BD COR System, an automated high-throughput diagnostic system. The BD COR System has set a new standard for viral disease analysis using robotics and sample management software algorithms. Such product launches for treating various diseases have significantly boosted the market's growth.
Multiplex Assays Market Report Highlights
Polaris Market Research has segmented the multiplex assays market report based on type, technology, application, end-use, and region:
Multiplex Assays, Type Outlook (Revenue - USD Million, 2019 - 2032)
Multiplex Assays, Technology Outlook (Revenue - USD Million, 2019 - 2032)
Multiplex Assays, Application Outlook (Revenue - USD Million, 2019 - 2032)
Multiplex Assays, End-Use Outlook (Revenue - USD Million, 2019 - 2032)
Multiplex Assays, Regional Outlook (Revenue - USD Million, 2019 - 2032)
Multiplex Assays Market Report Scope
Report Attributes |
Details |
Market size value in 2024 |
USD 4107.7 million |
Revenue forecast in 2032 |
USD 8,136.7 million |
CAGR |
8.9% from 2024 – 2032 |
Base year |
2023 |
Historical data |
2019 – 2022 |
Forecast period |
2024 – 2032 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2032 |
Segments Covered |
By Type, By Technology, By Application, By End-Use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Customization |
Report customization as per your requirements with respect to countries, region, and segmentation. |
For Specific Research Requirements |